global-alert
global messaging alerts

ApiJect Chief Global Health Officer Ed Kelley to Participate in INTERPHEX Live

INTERPHEX Live offers prerecorded interviews and discussion on the latest, cutting-edge pharmaceutical and biopharmaceutical technologies. INTERPHEX Live is part of the technical conference at INTERPHEX, taking place October 19-21, 2021, in New York, NY. Sessions will be available online beginning October 19, 2021. Join Dr. Kelley as he participates in two sessions:

“Pros and Cons of Global Fill-Finish” Responding to the COVID-19 pandemic, governments and public health agencies worldwide are developing quality vaccine programs, including local fill-finish capacity, to support global immunization. Yet even before COVID, countries were already facing increased vaccine demand due to population growth. The panel will discuss key challenges and opportunities as governments and pharmaceutical manufacturers seek to establish fill-finish facilities around the world to enable access to greater and more diversified vaccine manufacturing while improving preparedness to respond to future pandemics.

Presenters: Ed Kelley, PhD, former Director of Integrated Health Services for WHO and Chief Global Health Officer for ApiJect; Jason Collins, AIA, Director of Process Architecture at IPS-Integrated Project Services; and Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals.

“Creating a Sustainable Public Health Supply Chain” Our expert panelists will share their insights on how stakeholders can maintain a robust, resilient supply chain essential to global health and vaccine security, with an accelerated response time to meet the needs of current and future pandemics. The building blocks for this supply chain resiliency include tech transfer, designing for right-size capacity, improving operational efficiencies, implementing state-of-the-art technologies, and establishing regulatory and quality systems.

Presenters: Ed Kelley, PhD, former Director of Integrated Health Services for WHO and Chief Global Health Officer for ApiJect; and Rob Roy, PE, Director of Aseptic Technology at IPS-Integrated Project Services; Paul Fisher, Director of Process Architecture at IPS-Integrated Project Services; and Jim Fries, Chief Executive Officer, RX-360.

For details on covering these events, please contact Kate Scott at kscott@apiject.com About ApiJect ApiJect Systems, Corp. is a public-benefit medical technology company working to bring prefilled, single-dose injections to more people in every market. The ApiJect Platform enables pharma companies to design scalable prefilled injectors and cost-effectively fill-finish on either their own ApiJect-licensed Blow-Fill-Seal packaging lines or at one of our world-class manufacturing partners. Learn more at www.apiject.com.

ABOUT APIJECT SYSTEMS, CORP.

ApiJect Systems, Corp. is a public-benefit medical technology company working to bring prefilled, single-dose injections to more people in every market. The ApiJect Platform enables pharmaceutical and biotech companies to design scalable prefilled injectors and efficiently fill-finish them with their injectable drug products. This can be done either on one of their own ApiJect-licensed Blow-Fill-Seal packaging lines or at one of our world-class manufacturing partners. Learn more at www.apiject.com or contact Steve Hofman at shofman@ext.apiject.com.

random footer image
Social media & sharing icons powered by UltimatelySocial
Twitter
YouTube
YouTube
LinkedIn
LinkedIn